The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes-Reference-Cited by-同舟云学术

The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes

Published:2021-11-17 Issue: Volume: Page:
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Chang Rong¹²,Wang Chunsheng¹²,Kong Xiangqi¹²,Li Wenhui¹²,Wu Jinchun³

Affiliation:

1. Department of Cardiovascular Medicine, Shenzhen Longhua District Central Hospital, Shenzhen 518110, Guangdong Province, China

2. Department of Cardiovascular Medicine, Longhua Hospital affiliated to Guangdong Medical University, Shenzhen 518110, Guangdong Province, China

3. Department of Cardiovascular Medicine, Qinghai Provincial People’s Hospital, Xining 810007, Qinghai Province, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Qinghai Province

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2003926

Reference27 articles.

1. [1] K. C. Tang, Z.P. Yang, Q. Zeng, et al. Effect of miR-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1. Biosci Rep. 2018 Dec 21; 38(6): BSR20180598.

2. [2] D. F. Akin‑Bali, T. Eroglu, S. Ilk, et al. Evaluation of the role of Nrf2/Keap1 pathway‑associated novel mutations and gene expression on antioxidant status in patients with deep vein thrombosis, Exp. Ther. Med. 2020;20(2):868-881.

3. [3] J. Lu, Q. Fang, X. Ge. Role and Mechanism of mir-5189-3p in Deep Vein Thrombosis of Lower Extremities. Ann Vasc Surg. 2021 Aug 17: S0890-5096(21)00492-1.

4. [4] Y. R. Jiang, L. L. Niu, N. Feng, et al. Correlation between the Polymorphism of Coagulation-Related Genes and Lower Extremity Deep Venous Thrombosis. Fa Yi Xue Za Zhi. 2021 Apr;37(2):145-150.

5. [5] S. Ju, Y. Gao, X. Cao, et al. Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study. Genet Test Mol Biomarkers. 2017 Sep;21(9):539-546.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statement of Retraction: The role of second generation sequencing technology and nanomedicine in the monitoring and treatment of lower extremity deep vein thrombosis susceptibility genes;Bioengineered;2024-01-29